DEL SAL, GIANNINO
 Distribuzione geografica
Continente #
NA - Nord America 13.554
EU - Europa 7.297
AS - Asia 6.178
SA - Sud America 689
AF - Africa 163
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 17
Totale 27.917
Nazione #
US - Stati Uniti d'America 13.394
SG - Singapore 2.295
PL - Polonia 1.781
CN - Cina 1.426
IT - Italia 1.186
UA - Ucraina 768
SE - Svezia 755
VN - Vietnam 663
HK - Hong Kong 573
DE - Germania 549
BR - Brasile 526
FI - Finlandia 481
KR - Corea 379
FR - Francia 378
GB - Regno Unito 328
TR - Turchia 316
RU - Federazione Russa 237
BG - Bulgaria 162
IE - Irlanda 161
NL - Olanda 153
IN - India 132
CH - Svizzera 103
AR - Argentina 69
BE - Belgio 69
CA - Canada 67
MA - Marocco 58
MX - Messico 55
BD - Bangladesh 49
JP - Giappone 48
ES - Italia 34
IQ - Iraq 33
ZA - Sudafrica 30
ID - Indonesia 29
SA - Arabia Saudita 28
AT - Austria 27
RO - Romania 27
PK - Pakistan 25
EC - Ecuador 22
UZ - Uzbekistan 20
IL - Israele 18
CO - Colombia 17
AE - Emirati Arabi Uniti 16
SN - Senegal 16
MY - Malesia 15
PH - Filippine 14
AU - Australia 13
CL - Cile 13
CZ - Repubblica Ceca 13
PA - Panama 13
VE - Venezuela 13
EG - Egitto 12
EU - Europa 12
KE - Kenya 12
TH - Thailandia 12
NP - Nepal 11
HU - Ungheria 10
PE - Perù 9
RS - Serbia 9
BO - Bolivia 8
DK - Danimarca 8
HR - Croazia 8
KZ - Kazakistan 8
LT - Lituania 8
QA - Qatar 8
JO - Giordania 7
TN - Tunisia 7
IR - Iran 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
CR - Costa Rica 5
DZ - Algeria 5
PS - Palestinian Territory 5
PY - Paraguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AZ - Azerbaigian 4
ET - Etiopia 4
GA - Gabon 4
GR - Grecia 4
JM - Giamaica 4
LB - Libano 4
LK - Sri Lanka 4
MD - Moldavia 4
TW - Taiwan 4
AM - Armenia 3
AO - Angola 3
BW - Botswana 3
CG - Congo 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
Totale 27.884
Città #
Warsaw 1.626
Fairfield 1.514
Ashburn 1.324
Woodbridge 1.308
Singapore 1.304
Ann Arbor 903
Houston 878
Chandler 864
Wilmington 713
Jacksonville 684
San Jose 654
Seattle 651
Hong Kong 564
Cambridge 452
Trieste 400
Hefei 396
Seoul 365
Beijing 363
Munich 282
Princeton 278
Izmir 269
Boardman 252
Helsinki 211
Chicago 197
Ho Chi Minh City 189
Los Angeles 164
Sofia 159
Dublin 156
Lauterbourg 150
Columbus 136
Hanoi 132
Zgierz 132
Dallas 101
Milan 93
Council Bluffs 90
Buffalo 87
Moscow 87
Bern 81
Frankfurt am Main 81
The Dalles 80
Santa Clara 75
San Diego 66
Brussels 64
Dearborn 63
New York 63
São Paulo 60
Des Moines 53
Casablanca 46
Düsseldorf 45
London 42
Shanghai 41
Tokyo 41
Verona 40
Orem 38
Atlanta 34
Bremen 33
Dong Ket 32
Haiphong 32
Turku 32
Da Nang 31
Falls Church 31
St Louis 31
Phoenix 30
Rome 30
Redmond 28
Nuremberg 26
Chennai 24
Nanjing 24
Norwalk 22
Brooklyn 20
Bucharest 20
Amsterdam 19
Jinan 19
Tianjin 19
Washington 19
Rio de Janeiro 18
Stockholm 18
Tashkent 17
Vienna 17
Dakar 16
Pune 16
Denver 15
Dhaka 15
Johannesburg 15
Kunming 15
Manchester 15
Montreal 15
Paris 15
Portsmouth 15
Hải Dương 14
Kocaeli 14
Roubaix 14
Toronto 14
Zurich 14
Mumbai 13
Auburn Hills 12
Brasília 12
Buenos Aires 12
Guangzhou 12
Jeddah 12
Totale 20.028
Nome #
Effects of Pin1 Loss in HdhQ111 Knock-in Mice 438
Mutant p53 improves cancer cells’ resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6 434
MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells 415
Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes 411
Glucocorticoid receptor signalling activates YAP in breast cancer 391
Complexes formed by mutant p53 and their roles in breast cancer 370
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action 366
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer 361
Mutant p53 as a guardian of the cancer cell 357
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells 347
Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations. 337
A fast method for high-quality genomic DNA extraction from whole human blood 336
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins 317
Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism 315
GDA, a web-based tool for Genomics and Drugs integrated analysis 313
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells 299
Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis 290
Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding 284
The CTAB-DNA precipitation Method:A common mini-scale preparation of template DNA from phagemids,phages or plasmids suitable for sequencing 278
The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stress 278
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer. 265
Metabolic control of YAP and TAZ by the mevalonate pathway 264
Exploring the impact of mechanical stress in neurodegeneration 264
HMGA1 inhibits the function of p53 family members in thyroid cancer cells 262
High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation 250
The cytoplasmic side of p53's oncosuppressive activities 249
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. 248
Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression 245
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 243
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast 243
The stiff RhoAd from mevalonate to mutant p53 240
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness 238
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 233
hGTSE-1 expression stimulates cytoplasmic localization of p53 231
Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death 225
Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP 222
Structure, function, and chromosome mapping of the growth-suppressing human homologue of the murine gas1 gene 221
Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP 218
Wiring the oncogenic circuitry: Pin1 unleashes mutant p53. 216
A Growth Arrest-Specific (gas) gene codes for a membrane protein 215
Identification of microRNAs targeting the DNA damage response in breast cancer 214
Breast cancer organoids model patient‐specific response to drug treatment 214
Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration 213
The prolyl-isomerase Pin1 activates the mitochondrial death program of p53. 208
MiR-181 family-specific behavior in different cancers: a meta-analysis view 208
Notch is a direct negative regulator of the DNA-damage response 206
Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships 205
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. 203
Pin1-dependent signalling negatively affects GABAergic transmission by modulating neuroligin2/gephyrin interaction 197
The transcriptional repressor hDaxx potentiates p53-dependent apoptosis 196
A simple and fast method for preparing single stranded DNA template suitable for sequencing 196
A one tube plasmid DNA minipreparation suitable for sequencing 196
Modification of the erythroid transcription factor GATA-1 by SUMO-1 194
Pin1 links the activities of c-Abl and p300 in regulating p73 function. 194
The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP 193
The rebel angel: Mutant p53 as the driving oncogene in breast cancer. 193
Gene regulation and tumor suppression by the bromodomain-containing protein BRD7. 191
Targeting triple negative breast cancer: is p53 the answer? 189
The PML nuclear bodies-associated protein TTRAP regulates ribosome biogenesis in nucleolar cavities upon proteasome inhibition. 185
Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target. 183
Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1 183
Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2 183
p73 as a Pharmaceutical Target for Cancer Therapy 182
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage 181
KeePin’ the p53 family in good shape. 181
A proline rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1 180
A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network 180
PIN1 in breast development and cancer: a clinical perspective 180
Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes. 178
Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease. 178
A proline rich motif in wild type p53 is required for transactivation independent growth arrest as induced by Gas1 177
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome 174
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening 171
A simple discountinuos buffer system for increased resolution and speed in gel electrophoretic analysis of DNA sequence 170
Dynamic landscape and regulation of RNA editing in mammals 170
Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection. 169
Pin1 and WWP2 regulate GluR2 Q/R site RNA editing by ADAR2 with opposing effects. 169
The prolyl-isomerase Pin1 is a novel Notch1 target that enhances Notch1 activation in cancer 167
The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage. 166
Prolyl isomerase Pin1 and protein kinase HIPK2 cooperate to promote cortical neurogenesis by suppressing groucho/TLE:Hes1-mediated inhibition of neuronal differentiation 165
Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. 164
Assignement of the E1A-regulated transcription factor gene(E4F17 to human chromosome band 16p13.3 by in situ hybridization and somatic cell hybrids 163
Immunohistochemical Characterization of a Renal Nephroblastoma in a Trp53-mutant and Prolyl Isomerase 1-deficient Mouse 163
The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells 161
A mutant p53/Hif1α/miR-30d axis reprograms the secretory pathway promoting the release of a prometastatic secretome 161
cDNA sequence analysis of an antibiotic dodecapeptide from neutrophils. 158
Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin. 155
The complexity of cell proliferation control in mammalian cells. 154
p53 is involved in the p120E4F-mediated growth arrest. 153
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. 151
HIV-1 Integrase Binding to its Cellular Partners: A Perspective from Computational Biology. 151
Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis 148
p53-Mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y. 148
Improving pharmacological rescue of p53 function: RITA targets mutant p53. 147
Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells. 146
The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function. 145
The Growth arrest specific gene, gas1, is involved in growth suppression 144
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53 143
Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. 142
Cell Cycle and Cancer:critical events at the G1 restriction point. 141
Totale 22.249
Categoria #
all - tutte 76.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021620 0 0 0 0 0 0 0 0 0 279 120 221
2021/20221.813 89 113 90 152 81 145 90 64 202 169 202 416
2022/20232.485 225 325 219 345 271 421 24 195 261 16 140 43
2023/20241.405 141 93 45 119 116 125 232 249 28 44 129 84
2024/20253.386 50 71 140 339 323 350 310 324 416 391 309 363
2025/20267.505 771 581 617 669 692 812 1.181 222 965 995 0 0
Totale 28.563